在瑞典为药物订单制定国家信息模型
Sofie Holmeland1,2, Tobias Blomberg2, Andreas Mårtensson2
1Health Informatics Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.
Methods of information in medicine
|February 27, 2025
概括
瑞典开发了一种新的电子健康记录 (EHR) 中药物订单的信息模型. 该模型增强了语义互操作性和数据的一致性,旨在减少药物错误并提高患者安全.
科学领域:
- 医疗信息学 医疗信息学
- 医疗信息系统 医疗信息系统
- 临床数据标准 临床数据标准
背景情况:
- 卫生信息系统 (HIS) 的语义互操作性,特别是电子健康记录 (EHR),对于明智的医疗保健决策和患者数据访问至关重要.
- 不一致的药物信息和有限的数据交换导致全球药物错误.
- 瑞典在交换药品订单和理解它们在EHR中的结构方面面临挑战.
研究的目的:
- 在瑞典医疗保健背景下,专门为瑞典电子健康记录 (EHR) 制定药物订单的共同信息模型.
- 解决药物订单交换的局限性和瑞典EHR之间的结构性理解.
主要方法:
- 采用了一个探索性的定性设计.
- 数据收集包括分析文件,参考模型,并与五位专家进行半结构面试.
- 分析包括信息需求,结构分析,以及对代码系统,分类和术语的检查.
主要成果:
- 确定了药物订单的关键信息领域:药物,适应症,施用,订单细节和剂量.
- 创建了一个统一建模语言类图信息模型,定义类,属性和数据类型.
- 该模型与国家药物清单保持一致,并增加了关键的药物订单细节.
结论:
- 开发的信息模型为瑞典的药品订单提供了潜在的国家标准.
- 它可以增强跨HIS的语义互操作性和数据交换.
- 预计这种标准化将改善数据的一致性,减少药物错误,并提高患者安全.
相关概念视频
Nursing Clinical Information System
746
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
746
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Guidelines for Nursing Documentation I
1.0K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.0K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
38
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
38
Drug Nomenclature
1.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.6K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54


